Chapter 17
Stem Cells and Cardiac Aging
Roberto Bolli MD,
Piero Anversa MD,
Roberto Bolli MD
Search for more papers by this authorPiero Anversa MD
Search for more papers by this authorRoberto Bolli MD,
Piero Anversa MD,
Roberto Bolli MD
Search for more papers by this authorPiero Anversa MD
Search for more papers by this authorBook Editor(s):Annarosa Leri MD,
Piero Anversa MD,
William H. Frishman MD,
Annarosa Leri MD
Professor of Medicine, Department of Medicine, Cardiovascular Research Institute, New York Medical College, Valhalla, NY
Search for more papers by this authorPiero Anversa MD
Professor of Medicine and Vice Chairman, Department of Medicine, Director, Cardiovascular Research Institute, New York Medical College, Valhalla, NY
Search for more papers by this authorWilliam H. Frishman MD
Rosenthal Professor and Chairman, Department of Medicine, New York Medical College, Director of Medicine, Westchester Medical Center, Valhalla, NY
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Introduction
-
The aging heart
-
Aging and myocardial infarction
-
Aging, oxidative stress, and cell death
-
Cellular senescence
-
Conclusions
-
Acknowledgments
References
- Wei JY. Age and the cardiovascular system. N Engl J Med 1992; 237: 1735–1739.
- Fong LG, Frost D, Meta M, et al. A protein farnesyltrans-ferase inhibitor ameliorates disease in a mouse model of progeria. Science 2006; 311: 1621–1623.
- Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003; 93: 604–613.
- Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulinlike growth factor-1 overexpression. Circ Res 2004; 94: 514–524.
- Rakusan K. Cardiac growth, maturation, and aging. In K Rakusan (ed.): Growth of the Heart in Health and Disease. New York: Raven Press, 131–164, 1984.
- Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995; 26: 1068–1079.
- Kang P, Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med 2003; 9: 177–182.
- Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990; 67: 871–885.
- Takahashi T, Schunkert H, Isoyama S, et al. Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J Clin Invest 1992; 89: 939–946.
- Anversa P, Fitzpatrick D, Argani S, Capasso JM. Myocyte mitotic division in the aging mammalian rat heart. Circ Res 1991; 69: 1159–1164.
- Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993; 329: 1442–1448.
- Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 2005; 102: 8692–8697.
- Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 2006; 113: 1451–1463.
- Dawn B, Stein AB, Urbanek K, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 2005; 102: 3766–3771.
- Rajindar SS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273: 59–63.
- Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719–7730.
- Higuchi M, Honda T, Proske RJ, Yeh ETH. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 1998; 17: 2753–2760.
- Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527–605.
- Arstall MA, Sawyer DB, Fukazawa R, Kelly RA. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 1999; 85: 829–840.
- Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999; 15: 562–571.
- Ing DJ, Zang J, Dzau VJ, et al. Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. Circ Res 1999; 84: 21–33.
- Cesselli D, Jakoniuk I, Barlucchi L, et al. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279–286.
- Frustaci A, Kajstura J, Chimenti C, et al. Myocardial cell death in human diabetes. Circ Res 2000; 87: 1123–1132.
- Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress and aging. Free Radic Biol Med 2000; 29: 222–230.
- Greenberg MM. In vitro and in vivo effects of oxidative damage to deoxyguanosine. Biochem Soc Trans 2004; 32: 46–50.
- DiMauro S, Tanji K, Bonilla E, et al. Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects. Muscle Nerve 2002; 26: 597–607.
- Okorokov AL, Ponchel F, Milner J. Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ss-DNA induces C-terminal cleavage of p53. EMBO J 1997; 16: 6008–6017.
- Leri A, Liu Y, Wang X, et al. Overexpression of IGF-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res 1999; 84: 752–762.
- Krajewski S, Krajewska M, Ellerby LM, et al. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA 1999; 96: 5752–5757.
- Li P-F, Dietz R, von Harsdorf R. P53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 1999; 18: 6027–6036.
- von Harsdorf R, Li P, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999; 99: 2934–2941.
- Hara E, Smith R, Parry D, et al. Regulation of p16CDKN2 expression and implication for cell immortalization and senescence. Mol Cell Biol 1996; 16: 859–867.
- Sherr CJ. Cell cycle control and cancer. Harvey Lect 2000-2001; 96: 73–92.
- Hayflick L. The cell biology of aging. J Invest Dermatol 1979; 73: 8–14.
- Sherr CJ, De Pinho RA. Cellular senescence: mitotic clock or culture shock. Cell 2000; 102: 407–410.
- Rubin H. Cell aging in vivo and in vitro. Mech Ageing Dev 1997; 98: 1–35.
- Cristofalo VJ, Allan RG, Pignolo RJ, et al. Relationship between donor age and replicative lifespan in culture, a reevaluation. Proc Natl Acad Sci USA 1998; 95: 10614–10619.
- Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363–9367.
- Greider CW. Cellular responses to telomere shortening: cellular senescence as a tumor suppressor mechanism. Harvey Lect 2000-2001; 96: 33–50.
- Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 10440–10445.
- Kajstura J, Pertoldi B, Leri A, et al. Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol 2000; 156: 813–819.
- Allsopp RC, Weissman IL. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene 2002; 21: 3270–3273.
- Lansdorp PM. Telomere length and proliferation potential of hematopoietic stem cells. J Cell Sci 1995; 108: 1–6.
- Geiger H, Van Zant G. The aging of lymphohematopoietic stem cells. Nat Immunol 2002; 3: 329–333.
- Morrison SJ, Wandycz AM, Akashi K, et al. The aging of hematopoietic stem cells. Nat Med 1996; 2: 1011–1016.
- Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446–2449.
- Hubbard K, Dhanaraj SN, Sethi KA, et al. Alteration of DNA and RNA binding activity of human telomere binding proteins occurs during cellular senescence. Exp Cell Res 1995; 218: 241–247.
- Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25–34.
- Hemann MT, Strong MA, Hao L-Y, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67–77.
- Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996; 5: 685–691.
